Vision-Ease Lens acquired by private equity investment firm
Monday, September 29 2014 | 00 h 00 min | News
Chicago-based private equity investment firm Wind Point Partners has acquired Vision-Ease Lens, manufacturer of LifeRx®, ChangeRx, SunRx, Coppertone®, Novel and Novella lenses. The terms of the deal were not disclosed.
Vision-Ease Lens was owned by Insight Equity, another private equity investment firm, this time based out of Dallas.
“This recapitalization with Wind Point Partners will enable our long-term growth in some key areas, while continuing our excellence in day-to-day operations,” said Doug Hepper, president and CEO of Vision-Ease Lens, in a news release. “We will also be able to devote more resources to global growth.”
Wind Point is confident the deal offers good value: “Vision-Ease Lens is a strong investment for our firm because of its long-standing stability and position as a market leader in value-added ophthalmic lenses, as well as the breadth of its products and strong brand reputation,” said Nathan Brown, a managing director at Wind Point.